Movement Disorders [clinicaltrials_resource:2f49ee06d0e25878dcefb6f5527c0d69]
Transcranial Magnetic Stimulation for the Treatment of Parkinson's Disease [clinicaltrials:NCT00001665]Genotype/Phenotype Correlation of Movement Disorders and Other Neurological Diseases [clinicaltrials:NCT00001667]Treatment of Parkinson's Disease With Eliprodil [clinicaltrials:NCT00001929]Effects of Talampanel on Patients With Advanced Parkinson's Disease [clinicaltrials:NCT00036296]Effects of Exercise Poles on Older Adults During Exercise Walking [clinicaltrials:NCT00037167]Farming and Movement Evaluation Study (FAME) [clinicaltrials:NCT00042120]Neurophysiological Studies in Patients With Paroxysmal Hyperkinetic Movement Disorders [clinicaltrials:NCT00056888]Physiology of Weakness in Movement Disorders [clinicaltrials:NCT00307346]Treatment for Psychogenic Disorders [clinicaltrials:NCT00314444]Sedation During Microelectrode Recordings Before Deep Brain Stimulation for Movement Disorders. [clinicaltrials:NCT00355927]Dyskinesia in Parkinson's Disease (Study P04501) [clinicaltrials:NCT00406029]clinicaltrials:NCT00467597Follow Up Safety Study of SCH 420814 in Subjects With Parkinson's Disease (P05175) [clinicaltrials:NCT00537017]Deep Brain Stimulation to Treat Symptoms of Parkinson's Disease [clinicaltrials:NCT00552474]Changes of the Neuronal Activity in the Subthalamic Nucleus Under Remifentanil Sedation During Stereotactic Electrode Implantation [clinicaltrials:NCT00588926]Study of Preladenant for the Treatment of Neuroleptic Induced Akathisia (Study P05145AM1)(COMPLETE) [clinicaltrials:NCT00693472]Changes in the Posterior Parietal Cortex - Primary Motor Cortex Pathway Induced by Motor Training [clinicaltrials:NCT00904332]Mood and Subthalamic Nucleus (STN) Deep Brain Stimulation [clinicaltrials:NCT00954772]Physiological Investigations of Movement Disorders [clinicaltrials:NCT01019343]The Norwegian Physical Therapy Study in Preterm Infants [clinicaltrials:NCT01089296]Genetics of Motor Learning [clinicaltrials:NCT01105845]Study of Blood Lactate Levels in Patients Treated With Antipsychotics [clinicaltrials:NCT01139463]Postural Effects of Being Rotated in a Whole Body Gyroscope [clinicaltrials:NCT01188161]Evaluation of the Efficacy and Safety of AFQ056 in Parkinson's Patients With L-dopa Induced Dyskinesias [clinicaltrials:NCT01385592]Effectiveness of a Wheelchair Skills Training Program for Power Mobility Users: A Randomized Controlled Trial [clinicaltrials:NCT01432418]Evaluation of the Efficacy and Safety of Modified Release AFQ056 in Parkinson's Patients With L-dopa Induced Dyskinesias [clinicaltrials:NCT01491529]Open-label, Long-term Safety Extension Study of AFQ056 in Parkinson's Patients With L-dopa Induced Dyskinesias [clinicaltrials:NCT01491932]Effect of Undenatured Cysteine-Rich Whey Protein Isolate (HMS 90®) in Patients With Parkinson's Disease [clinicaltrials:NCT01662414]Surface EMG Biofeedback for Children With Cerebral Palsy [clinicaltrials:NCT01681888]Treatment of Functional Movement Disorders With Psychotherapy [clinicaltrials:NCT01778517]Effectiveness of Vojta Therapy in Motor Development of Preterm Children [clinicaltrials:NCT01838278]A Study of Movement Disorders Using the QMAT At-Home Testing Device [clinicaltrials:NCT01905839]Evaluation of Diffusion MRI as a Tool in Planning Deep Brain Stimulation (DBS) [clinicaltrials:NCT01975532]Inhibitory rTMS in Dystonic Wilson Patients [clinicaltrials:NCT01980433]Deep Brain Stimulation Therapy in Movement Disorders [clinicaltrials:NCT02119611]Validation of DaTscan for Detection of Parkinson Disease Related Disorders [clinicaltrials:NCT02138682]ExAblate Transcranial MRgFUS for the Management of Treatment-Refractory Movement Disorders [clinicaltrials:NCT02252380]BIS and Entropy in Deep Brain Simulation [clinicaltrials:NCT02386995]Feasibility Study of Deep Brain Recordings for Learning and Memory [clinicaltrials:NCT02417727]rTMS Effect in Functional Psychogenic Movement Disorders Applied Alone Then Combined With Hypnotherapy [clinicaltrials:NCT02471066]
condition [clinicaltrials_vocabulary:condition]
Botulinum Toxin for the Treatment of Involuntary Movement Disorders [clinicaltrials:NCT00001208]Human Movement Database [clinicaltrials:NCT00001252]PET Scan to Study Brain Control of Human Movement [clinicaltrials:NCT00001324]Magnetic Resonance Imaging Studies of Motor and Thought Processes [clinicaltrials:NCT00001361]Diagnosis and Natural History Study of Patients With Neurological Conditions [clinicaltrials:NCT00001549]Treatment of Cortical Myoclonus With Repetitive Transcranial Magnetic Stimulation [clinicaltrials:NCT00001663]Transcranial Magnetic Stimulation for the Treatment of Parkinson's Disease [clinicaltrials:NCT00001665]Genotype/Phenotype Correlation of Movement Disorders and Other Neurological Diseases [clinicaltrials:NCT00001667]Magnetic Stimulation of the Human Nervous System [clinicaltrials:NCT00001780]Treatment of Parkinson's Disease With Eliprodil [clinicaltrials:NCT00001929]Brain Excitability During Self-Paced Voluntary Movements [clinicaltrials:NCT00017966]Study of Brain Control of Movement [clinicaltrials:NCT00017979]Phenotype/Genotype Correlations in Movement Disorders [clinicaltrials:NCT00018889]Effects of Talampanel on Patients With Advanced Parkinson's Disease [clinicaltrials:NCT00036296]Effects of Exercise Poles on Older Adults During Exercise Walking [clinicaltrials:NCT00037167]Farming and Movement Evaluation Study (FAME) [clinicaltrials:NCT00042120]Single Photon Emission Computed Tomography (SPECT) to Study Paroxysmal Hyperkinetic Movement Disorders [clinicaltrials:NCT00051337]Neurophysiological Studies in Patients With Paroxysmal Hyperkinetic Movement Disorders [clinicaltrials:NCT00056888]Genetic Characterization of Parkinson's Disease [clinicaltrials:NCT00105131]Ethyl-Eicosapentaenoic Acid and Tardive Dyskinesia [clinicaltrials:NCT00114595]Treatment of Tardive Dyskinesia With Galantamine [clinicaltrials:NCT00164242]Levetiracetam in the Treatment of Neuroleptic-induced Tardive Dyskinesia [clinicaltrials:NCT00175955]Piracetam for Treatment Tardive Dyskinesia [clinicaltrials:NCT00190008]A Study of Istradefylline (KW-6002) as Monotherapy in Parkinson's Disease (PD) Patients [clinicaltrials:NCT00199433]Psychiatric Correlates of Psychogenic Movement Disorder and Non-Epileptic Seizure [clinicaltrials:NCT00255411]Movement Disorders Caused by Antipsychotic Drugs in Older Patients [clinicaltrials:NCT00255879]Levetiracetam Treatment of Tardive Dyskinesia [clinicaltrials:NCT00291213]Physiology of Weakness in Movement Disorders [clinicaltrials:NCT00307346]clinicaltrials:NCT00310661Treatment for Psychogenic Disorders [clinicaltrials:NCT00314444]Efficacy and Safety of Deep Brain Stimulation (DBS) of the Pallidal (GPi) in Patients With Tardive Dystonia [clinicaltrials:NCT00331669]Sedation During Microelectrode Recordings Before Deep Brain Stimulation for Movement Disorders. [clinicaltrials:NCT00355927]Dyskinesia in Parkinson's Disease (Study P04501) [clinicaltrials:NCT00406029]Brain Activity in People With Functional Movement Disorders [clinicaltrials:NCT00448084]clinicaltrials:NCT00467597Neurobiology of Psychogenic Movement Disorder and Non-Epileptic Seizures [clinicaltrials:NCT00500994]A Proof of Concept Study of the Effectiveness of Carisbamate in the Treatment of Essential Tremor [clinicaltrials:NCT00524056]Follow Up Safety Study of SCH 420814 in Subjects With Parkinson's Disease (P05175) [clinicaltrials:NCT00537017]Deep Brain Stimulation to Treat Symptoms of Parkinson's Disease [clinicaltrials:NCT00552474]Changes of the Neuronal Activity in the Subthalamic Nucleus Under Remifentanil Sedation During Stereotactic Electrode Implantation [clinicaltrials:NCT00588926]
condition browse [clinicaltrials_vocabulary:condition-browse]
Botulinum Toxin for the Treatment of Involuntary Movement Disorders [clinicaltrials:NCT00001208]Human Movement Database [clinicaltrials:NCT00001252]PET Scan to Study Brain Control of Human Movement [clinicaltrials:NCT00001324]Magnetic Resonance Imaging Studies of Motor and Thought Processes [clinicaltrials:NCT00001361]Diagnosis and Natural History Study of Patients With Neurological Conditions [clinicaltrials:NCT00001549]Treatment of Cortical Myoclonus With Repetitive Transcranial Magnetic Stimulation [clinicaltrials:NCT00001663]Transcranial Magnetic Stimulation for the Treatment of Parkinson's Disease [clinicaltrials:NCT00001665]Genotype/Phenotype Correlation of Movement Disorders and Other Neurological Diseases [clinicaltrials:NCT00001667]Magnetic Stimulation of the Human Nervous System [clinicaltrials:NCT00001780]Treatment of Parkinson's Disease With Eliprodil [clinicaltrials:NCT00001929]Brain Excitability During Self-Paced Voluntary Movements [clinicaltrials:NCT00017966]Study of Brain Control of Movement [clinicaltrials:NCT00017979]Phenotype/Genotype Correlations in Movement Disorders [clinicaltrials:NCT00018889]Effects of Talampanel on Patients With Advanced Parkinson's Disease [clinicaltrials:NCT00036296]Effects of Exercise Poles on Older Adults During Exercise Walking [clinicaltrials:NCT00037167]Farming and Movement Evaluation Study (FAME) [clinicaltrials:NCT00042120]Single Photon Emission Computed Tomography (SPECT) to Study Paroxysmal Hyperkinetic Movement Disorders [clinicaltrials:NCT00051337]Neurophysiological Studies in Patients With Paroxysmal Hyperkinetic Movement Disorders [clinicaltrials:NCT00056888]Genetic Characterization of Parkinson's Disease [clinicaltrials:NCT00105131]Ethyl-Eicosapentaenoic Acid and Tardive Dyskinesia [clinicaltrials:NCT00114595]Treatment of Tardive Dyskinesia With Galantamine [clinicaltrials:NCT00164242]Levetiracetam in the Treatment of Neuroleptic-induced Tardive Dyskinesia [clinicaltrials:NCT00175955]Piracetam for Treatment Tardive Dyskinesia [clinicaltrials:NCT00190008]A Study of Istradefylline (KW-6002) as Monotherapy in Parkinson's Disease (PD) Patients [clinicaltrials:NCT00199433]Psychiatric Correlates of Psychogenic Movement Disorder and Non-Epileptic Seizure [clinicaltrials:NCT00255411]Movement Disorders Caused by Antipsychotic Drugs in Older Patients [clinicaltrials:NCT00255879]Levetiracetam Treatment of Tardive Dyskinesia [clinicaltrials:NCT00291213]Physiology of Weakness in Movement Disorders [clinicaltrials:NCT00307346]clinicaltrials:NCT00310661Treatment for Psychogenic Disorders [clinicaltrials:NCT00314444]Efficacy and Safety of Deep Brain Stimulation (DBS) of the Pallidal (GPi) in Patients With Tardive Dystonia [clinicaltrials:NCT00331669]Sedation During Microelectrode Recordings Before Deep Brain Stimulation for Movement Disorders. [clinicaltrials:NCT00355927]Dyskinesia in Parkinson's Disease (Study P04501) [clinicaltrials:NCT00406029]Brain Activity in People With Functional Movement Disorders [clinicaltrials:NCT00448084]clinicaltrials:NCT00467597Neurobiology of Psychogenic Movement Disorder and Non-Epileptic Seizures [clinicaltrials:NCT00500994]A Proof of Concept Study of the Effectiveness of Carisbamate in the Treatment of Essential Tremor [clinicaltrials:NCT00524056]Follow Up Safety Study of SCH 420814 in Subjects With Parkinson's Disease (P05175) [clinicaltrials:NCT00537017]Deep Brain Stimulation to Treat Symptoms of Parkinson's Disease [clinicaltrials:NCT00552474]Changes of the Neuronal Activity in the Subthalamic Nucleus Under Remifentanil Sedation During Stereotactic Electrode Implantation [clinicaltrials:NCT00588926]
condition mesh [clinicaltrials_vocabulary:condition-mesh]
Movement Disorders [clinicaltrials_resource:2f49ee06d0e25878dcefb6f5527c0d69]
Bio2RDF identifier
2f49ee06d0e25878dcefb6f5527c0d69
Bio2RDF namespace
clinicaltrials_resource
Bio2RDF uri
http://bio2rdf.org/clinicaltrials_resource:2f49ee06d0e25878dcefb6f5527c0d69
identifier
clinicaltrials_resource:2f49ee06d0e25878dcefb6f5527c0d69
title
Movement Disorders
@en
type
label
Movement Disorders [clinicaltrials_resource:2f49ee06d0e25878dcefb6f5527c0d69]
@en
Movement Disorders